investorscraft@gmail.com

Ginkgo Bioworks Holdings, Inc. (DNA)

Previous Close
$12.72
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)149.401075
Intrinsic value (DCF)0.00-100
Graham-Dodd Methodn/a
Graham Formula13.113

Company Information

27 Drydock Avenue
Boston, MA 02210
United States
Phone: 877 422 5362
Industry: Biotechnology
Sector: Healthcare
CEO: Dr. Jason Kelly Ph.D.
Full Time Employees: 834

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

HomeMenuAccount